You are using an older browser version. Please use a supported version for the best MSN experience.

Regeneron CEO: We'll likely have to constantly adapt our antibody cocktail

Dr. Leonard Schleifler, founder and CEO of Regeneron, joins "Squawk Box" to discuss the company's monoclonal antibody treatment and the omicron variant.

UP NEXT

UP NEXT

image beaconimage beaconimage beacon